Literature DB >> 23579400

Fatal anaphylactoid reaction associated with heparin-induced thrombocytopenia.

Atul Singla1, Mohammad R Amini, Martin A Alpert, Heather L Gornik.   

Abstract

Acute systemic (anaphylaxis and anaphylactoid) reactions have been well described in patients with heparin-induced thrombocytopenia (HIT). Both necrotizing and non-necrotizing skin lesions at heparin injection sites have been reported and may occur in 10-20% of patients with HIT. We report herein a patient treated with subcutaneous enoxaparin sodium who developed non-necrotizing erythematous skin lesions at enoxaparin sodium injection sites. A subsequent intravenous bolus of unfractionated heparin produced a fatal anaphylactoid reaction. This suggests that caution should be exercised in the administration of intravenous heparin to patients with non-necrotizing erythematous skin lesions at prior heparin injection sites.

Entities:  

Keywords:  heparin; low-molecular weight heparin; skin

Mesh:

Substances:

Year:  2013        PMID: 23579400     DOI: 10.1177/1358863X13483865

Source DB:  PubMed          Journal:  Vasc Med        ISSN: 1358-863X            Impact factor:   3.239


  2 in total

Review 1.  Novel oral anticoagulants for heparin-induced thrombocytopenia.

Authors:  Jessica W Skelley; Jeffrey A Kyle; Rachel A Roberts
Journal:  J Thromb Thrombolysis       Date:  2016-08       Impact factor: 2.300

2.  Early recognition is the key to success: pulseless electrical activity (PEA) as a manifestation of heparin-induced anaphylactoid reaction.

Authors:  Apoorva Jayarangaiah; Narendranath Epperla
Journal:  BMJ Case Rep       Date:  2015-11-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.